Ryan Damon - Dec 16, 2021 Form 4 Insider Report for Criteo S.A. (CRTO)

Signature
/s/Ryan Damon
Stock symbol
CRTO
Transactions as of
Dec 16, 2021
Transactions value $
-$124,900
Form type
4
Date filed
12/20/2021, 03:11 PM
Previous filing
Oct 27, 2021
Next filing
Jan 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRTO Ordinary Shares Sale -$125K -3.05K -2.51% $41.00 118K Dec 16, 2021 Direct F1, F2, F3
transaction CRTO Ordinary Shares Options Exercise $316K +7.72K +6.52% $41.01 126K Dec 16, 2021 Direct F1, F3
transaction CRTO Ordinary Shares Sale -$316K -7.72K -6.12% $41.01 118K Dec 16, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRTO Stock Option (right to buy) Options Exercise $0 -7.72K -31.42% $0.00 16.8K Dec 16, 2021 Ordinary Shares 7.72K $21.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.00 to $41.03, inclusive. The reporting person undertakes to provide to any security holder of Criteo S.A. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
F4 Stock options granted on October 25, 2018. One-fourth of the grant vests on the first anniversary of the grant date and additional 1/16th of the grant vests quarterly thereafter for a period of 36 months, subject to continued service through each vesting date.